Transcatheter Aortic Valve Replacement Market to Surge at a CAGR of Around 13.61% During 2025-30

• Overview
• Table of Content
• Research Methodology
• Download Free Sample

The Global Transcatheter Aortic Valve Replacement Market size was valued at around USD4,121 million in 2024 and is projected to reach USD8,862 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 13.61% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. The rise in the market is due to an increase in the aging population, development of the healthcare infrastructure, government support, innovation of advances such as balloon & self-expanding valves, advances in materials, and others.

The lifespan of an individual has reached over 70 years, due to the advances in the health sector; however, the non-stop functioning of the delicate aortic valves for a longer duration under stress and hypertension leads to the dysfunction of the aortic valve and related disorders like aortic stenosis and aortic regurgitation. These dysfunctions lead to the need for replacement among the aging population, increasing the demand for the transcatheter aortic valve replacement procedure worldwide.   

Moreover, the innovation of new technologies, such as balloon-expandable valves, has surged due to the shift towards the development of next-generation technology, easy deployment, and enhanced post-surgery outcomes. The balloon-expandable mechanism of the valves offers easier access to the arteries and veins of the heart if needed in the future, hence leading to their use in more than 50% of the TAVR surgeries. Thus, the growing high-tech healthcare industry, increasing aging population, and advancements boost the market growth worldwide, further states the research report, “Global Transcatheter Aortic Valve Replacement Market Analysis, 2025.”

Global Transcatheter Aortic Valve Replacement Market Segmentation Analysis

Nitinol is the Most Preferred Material Type

Based on the material type, the market is further bifurcated into nitinol, cobalt chromium, stainless steel, and others. The nitinol holds the majority of the market share of around 41%. This is due to its unique composition, lower post-surgery complications, compatibility with bio matter, flexibility, high productivity, etc. The nitinol is a specialty metal made from a blend of nickel and titanium, having unique properties such as memory shape and stretch. This unique property of the nitinol makes it compatible for the integration into the distinctive patient's heart. The valve is flexible, adjusting to the shape of the aortic valve of the patient, reducing the leak and offering a streamlined flow of blood into the heart and its chambers.

Moreover, the memory shape and stretchability make it the perfect choice for the self-expanding aortic valves. The nitinol self-expanding aortic valve is inserted into the body through a small tube, which takes the needed and accurate size in the heart, thus further minimizing the invasion. Several companies, such as Medtronic, LivaNova, Edwards Lifesciences, etc., are providing nitinol TAVR for the effective management of the blood flow and opening of the valve. Thus, the compatibility and distinctive properties of the nitinol, primarily in the self-expanding aortic valves, increase the demand, hence facilitating the large market share of the segment globally.

North America Leads the Transcatheter Aortic Valve Replacement Industry Globally

North America dominates the transcatheter aortic valve replacement industry globally by more than 43%. This is due to the advanced and mature healthcare sector, frequent investment in the healthcare infrastructure, strong presence of market players, a growing aging population, government support, etc. The healthcare sector in North America is expanding with the integration of high-tech & advanced equipment and technologies. The upgraded healthcare includes the transcatheter aortic valve replacement procedure for the betterment of individuals suffering from aortic valve dysfunction, thus increasing the acceptance of the TAVR.

Additionally, the government-funded insurance system, like the Centers for Medicare & Medicaid Services (CMS), offers financial support to patients suffering from aortic stenosis and aortic regurgitation, aiding in their treatment procedure. Thus, frequent investments in the healthcare institutions & technologies, government support, and presence of key market players in the region increase the utility of transcatheter aortic valve replacement in North America.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading transcatheter aortic valve replacement companies in the global market, including Abbott Laboratories, Boston Scientific Corporation, Blue Sail Medical Co. Ltd., Bracco SpA, Edward Lifesciences, JC Medical Inc., JenaValve Technologies Inc., Medtronic Plc, Meril Lifesciences, Venus Medtech, St. Jude Medical, Inc., Coroneo Inc., Thubrikar Aortic Valve Inc., and others, are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the globe?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping up across various regions?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?